0001250853-23-000046.txt : 20230801
0001250853-23-000046.hdr.sgml : 20230801
20230801153726
ACCESSION NUMBER: 0001250853-23-000046
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230801
DATE AS OF CHANGE: 20230801
EFFECTIVENESS DATE: 20230801
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CENTRAL INDEX KEY: 0001335105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202903526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-488474
FILM NUMBER: 231131397
BUSINESS ADDRESS:
STREET 1: 248 ROUTE 25A
STREET 2: NO. 2
CITY: EAST SETAUKET
STATE: NY
ZIP: 11733
BUSINESS PHONE: 310 203 2902
MAIL ADDRESS:
STREET 1: 248 ROUTE 25A
STREET 2: NO. 2
CITY: EAST SETAUKET
STATE: NY
ZIP: 11733
FORMER COMPANY:
FORMER CONFORMED NAME: SRKP 7 INC
DATE OF NAME CHANGE: 20050803
D
1
primary_doc.xml
X0708
D
LIVE
0001335105
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
11733
6318307092
DELAWARE
SRKP 7 INC
Corporation
true
John
Kovach
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
91101
Executive Officer
Director
James
Miser
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
91101
Executive Officer
Robert
Weingarten
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
91101
Executive Officer
Eric
Forman
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
91101
Executive Officer
Stephen
Forman
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
91101
Director
Regina
Brown
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
91101
Director
Yun
Yen
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
91101
Director
Rene
Bernards
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
91101
Director
Bas
van der Baan
680 East Colorado Boulevard
Suite 180
Pasadena
CA
CALIFORNIA
91101
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-07-20
false
true
false
3500000
A.G.P. / ALLIANCE GLOBAL PARTNERS
8361
None
None
88 POST ROAD WEST
2ND FLOOR
WESTPORT
CT
CONNECTICUT
06880
NY
NEW YORK
false
3500000
3500000
0
The common stock warrants being offered hereunder are being offered as part of a broader offering which includes the public sale of shares of common stock and pre-funded warrants. The total offering amount is $3,500,000.
false
1
210000
0
0
false
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
/s/ John S. Kovach
John S. Kovach
Chief Executive Officer
2023-08-01